Skip to content

Clinical trials

Recruiting Phase 2/3 trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Recruiting Country / region: Norway Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20151
20181
20202
20212
20232
20241
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Bambino Gesù Hospital and Research Institute1
Blueprint Medicines Corporation1
CSL Behring1
CatalYm GmbH1
Celgene1
Centre Leon Berard1
Chiesi Farmaceutici S.p.A.1
Eikon Therapeutics1
Kartos Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Anorexia1
Atherosclerosis1
Cachexia1
Coronary Artery Disease1
Diabetes Mellitus1
Endometrial Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.